Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500099734Phase 4Not yet recruiting
Phase 4, open-label, single-arm trial of calcium gluconate + zinc gluconate, sponsored by The First Affiliated Hospital of Hebei North University. Primary endpoints: Changes in diet, BMI (mean change value, improvement rate, recurrence rate) and 1 more. Planned start Mar 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500099734.